Answers are grounded in this paper and cite their sources.
WHEN Dr. Utiger called to invite me to give this lecture, we agreed that it would be acceptable to review some highlights of progress in the field of GH research. By choosing the title “A Tale of Stature,” discretion, if not modesty, dictates that I make only sparing reference to our own work. The choice of title also allows me artistic license to make some interpretive comments. Maury Raben of course is best known for his isolation of hGH and his demonstration that it is an effective therapeutic agent in the treatment of hypopituitary dwarfism. In addition, he performed some important studies on its mechanism of action. But few among you, I suspect, know about some of his other achievements. He studied the mechanism of action of antithyroid drugs in association with Ted Astwood. He developed the first liquid scintillation counter and, had he chosen to patent the process and follow through on it, he might have gained considerable fortune, but that simply was not his style. In his later years as Director of Cardiovascular Research at the New England Center Hospital in Boston he continued to make important contributions in the field. Many fellows who were with him over the years have now, in their own right, become luminaries in the academic world and continue to make important scholarly contributions in endocrinology and metabolism and cardiac research.
No takes yet. Share an insight, caveat, or question.
Henry G. Friesen (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: